FI20021617A0 - Diagnostisia ja terapeuttisia menetelmiä - Google Patents

Diagnostisia ja terapeuttisia menetelmiä

Info

Publication number
FI20021617A0
FI20021617A0 FI20021617A FI20021617A FI20021617A0 FI 20021617 A0 FI20021617 A0 FI 20021617A0 FI 20021617 A FI20021617 A FI 20021617A FI 20021617 A FI20021617 A FI 20021617A FI 20021617 A0 FI20021617 A0 FI 20021617A0
Authority
FI
Finland
Prior art keywords
diagnostic
therapeutic procedures
therapeutic
procedures
Prior art date
Application number
FI20021617A
Other languages
English (en)
Swedish (sv)
Other versions
FI113666B (fi
FI20021617A (fi
Inventor
Annamari Ranki
Leena Karenko
Marketta Kaehkoenen
Ritva Karhu
Tapio Visakorpi
Original Assignee
Annamari Ranki
Leena Karenko
Marketta Kaehkoenen
Ritva Karhu
Tapio Visakorpi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20020132A external-priority patent/FI20020132A/fi
Publication of FI20021617A0 publication Critical patent/FI20021617A0/fi
Priority to FI20021617A priority Critical patent/FI113666B/fi
Application filed by Annamari Ranki, Leena Karenko, Marketta Kaehkoenen, Ritva Karhu, Tapio Visakorpi filed Critical Annamari Ranki
Priority to EP03700329A priority patent/EP1476567A1/en
Priority to JP2003566246A priority patent/JP4782378B2/ja
Priority to US10/502,638 priority patent/US7803532B2/en
Priority to PCT/FI2003/000061 priority patent/WO2003066898A1/en
Priority to AU2003201630A priority patent/AU2003201630A1/en
Priority to CA 2474446 priority patent/CA2474446A1/en
Publication of FI20021617A publication Critical patent/FI20021617A/fi
Publication of FI113666B publication Critical patent/FI113666B/fi
Application granted granted Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
FI20021617A 2002-01-24 2002-09-10 Menetelmiä, joissa käytetään kromosomin 12 spesifisiä katkoskohtia ja/tai neuroninavigaattori 3 -geeniä ihon primaaristen T-solulymfoomien diagnosoimiseksi ja taudin etenemisen seuraamiseksi tai ennustamiseksi, sekä näiden katkoskohtien ja geenien käyttö FI113666B (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20021617A FI113666B (fi) 2002-01-24 2002-09-10 Menetelmiä, joissa käytetään kromosomin 12 spesifisiä katkoskohtia ja/tai neuroninavigaattori 3 -geeniä ihon primaaristen T-solulymfoomien diagnosoimiseksi ja taudin etenemisen seuraamiseksi tai ennustamiseksi, sekä näiden katkoskohtien ja geenien käyttö
EP03700329A EP1476567A1 (en) 2002-01-24 2003-01-24 A method for the diagnosis of lymphoproliferative diseases
CA 2474446 CA2474446A1 (en) 2002-01-24 2003-01-24 A method for the diagnosis of lymphoproliferative diseases
JP2003566246A JP4782378B2 (ja) 2002-01-24 2003-01-24 リンパ球異常増殖疾患の診断方法
US10/502,638 US7803532B2 (en) 2002-01-24 2003-01-24 Method for the diagnosis of lymphoproliferative diseases
PCT/FI2003/000061 WO2003066898A1 (en) 2002-01-24 2003-01-24 A method for the diagnosis of lymphoproliferative diseases
AU2003201630A AU2003201630A1 (en) 2002-01-24 2003-01-24 A method for the diagnosis of lymphoproliferative diseases

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FI20020132 2002-01-24
FI20020132A FI20020132A (fi) 2002-01-24 2002-01-24 Diagnostisia ja terapeuttisia menetelmiä
FI20021617 2002-09-10
FI20021617A FI113666B (fi) 2002-01-24 2002-09-10 Menetelmiä, joissa käytetään kromosomin 12 spesifisiä katkoskohtia ja/tai neuroninavigaattori 3 -geeniä ihon primaaristen T-solulymfoomien diagnosoimiseksi ja taudin etenemisen seuraamiseksi tai ennustamiseksi, sekä näiden katkoskohtien ja geenien käyttö

Publications (3)

Publication Number Publication Date
FI20021617A0 true FI20021617A0 (fi) 2002-09-10
FI20021617A FI20021617A (fi) 2003-07-25
FI113666B FI113666B (fi) 2004-05-31

Family

ID=26161265

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20021617A FI113666B (fi) 2002-01-24 2002-09-10 Menetelmiä, joissa käytetään kromosomin 12 spesifisiä katkoskohtia ja/tai neuroninavigaattori 3 -geeniä ihon primaaristen T-solulymfoomien diagnosoimiseksi ja taudin etenemisen seuraamiseksi tai ennustamiseksi, sekä näiden katkoskohtien ja geenien käyttö

Country Status (7)

Country Link
US (1) US7803532B2 (fi)
EP (1) EP1476567A1 (fi)
JP (1) JP4782378B2 (fi)
AU (1) AU2003201630A1 (fi)
CA (1) CA2474446A1 (fi)
FI (1) FI113666B (fi)
WO (1) WO2003066898A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1977003A4 (en) * 2005-12-22 2009-11-11 Dermagene Oy DISEASE-RELATED METHODS AND MEDIUM
AU2007321070B2 (en) * 2006-11-13 2013-11-21 Valipharma Methods and uses involving genetic abnormalities at chromosome 12
US20100203536A1 (en) * 2007-09-20 2010-08-12 Kai Krohn Diagnostics of b-cell lymphoma
US20110091482A1 (en) * 2008-04-11 2011-04-21 The Regents Of The University Of Colorado, A Body Corporate Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis
DK2350316T3 (da) * 2008-10-20 2014-05-05 Valipharma Fremgangsmåder og anvendelser der involverer genetiske aberrationer af nav3 og aberrerende ekspression af multiple gener
US20220378780A1 (en) * 2019-09-23 2022-12-01 Neonc Technologies, Inc. Pharmaceutical compositions comprising poh derivatives
EP4122494A4 (en) 2020-03-16 2024-04-24 Mandom Corp METHOD FOR DETECTING A T-CELL LYMPHOMA INDICATOR AND USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007994A (en) * 1995-12-22 1999-12-28 Yale University Multiparametric fluorescence in situ hybridization
US20100203536A1 (en) * 2007-09-20 2010-08-12 Kai Krohn Diagnostics of b-cell lymphoma

Also Published As

Publication number Publication date
FI113666B (fi) 2004-05-31
FI20021617A (fi) 2003-07-25
CA2474446A1 (en) 2003-08-14
JP2005518790A (ja) 2005-06-30
JP4782378B2 (ja) 2011-09-28
AU2003201630A1 (en) 2003-09-02
EP1476567A1 (en) 2004-11-17
US7803532B2 (en) 2010-09-28
US20050221309A1 (en) 2005-10-06
WO2003066898A1 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
DE60331861D1 (de) Ultraschallverfahren und ultraschallgerät
DE60301989D1 (de) Medizinisches Ultraschallsystem
NO20041872L (no) Esterforbindelser og medisinsk anvendelse derav
NO20034465D0 (no) Medisinsk pasientsimulator
DE60307147D1 (de) Chirurgisches Ultraschallgerät
DE60327236D1 (de) Medizinisches biopsieinstrument
DE60312780D1 (de) Wegwerfwindel
DE60315135D1 (de) Therapiesonde
SE0203190L (sv) Anordning och förfarande
DE60237823D1 (de) Medizinisches behandlungsinstrument
DE60235204D1 (de) Medizinische leitung und leitungsverbindungssystem
DE60328797D1 (de) Blutbehandlungsgerät
DE50311558D1 (de) Inhalationstherapievorrichtung
EP1572741A4 (en) DIAGNOSTIC AND THERAPEUTIC AGENTS
NO20050689L (no) Terapeutisk anvendelse
DE50209220D1 (de) Medizinische Zange
SE0301997L (sv) Anordning och förfarande
DE50300206D1 (de) Medizinisches instrument
DK1597171T3 (da) Terapeutisk mikroskum
DE502004005673D1 (de) Medizinisches Instrument
EP1471822A4 (en) DYE-BIOKON JUGATE FOR SIMULTANEOUS OPTICAL DIAGNOSIS AND THERAPEUTIC APPLICATIONS
DE50303099D1 (de) Patientenlagerungstisch
FI20021617A0 (fi) Diagnostisia ja terapeuttisia menetelmiä
DK1553950T3 (da) Terapeutisk behandling
DE112004001618D2 (de) Pharmazeutischer Wirkstoff gegen Tumorerkrankungen

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: HELSINGIN YLIOPISTO

Free format text: HELSINGIN YLIOPISTO

PC Transfer of assignment of patent

Owner name: DERMAGENE OY

Free format text: DERMAGENE OY

PC Transfer of assignment of patent

Owner name: HELSINGIN YLIOPISTON RAHASTOT

Free format text: HELSINGIN YLIOPISTON RAHASTOT

PC Transfer of assignment of patent

Owner name: VALIPHARMA

MM Patent lapsed